ENTPD1 and cancer: Finally, cancer-cell-intrinsic inflammatory tumor subclusters also showed an upregulation of the ectonucleotidase CD39 (ENTPD1; log2FC = 0.47), which is associated with resistance to immune-checkpoint blockade70 and worse prognosis71 in ccRCC.